Home
About
Directory
Promoted Listings
Purchase Data
Drug Pipelines
Data Licensing
Newsletter
Contact
Symetis
is defunct.
Acquired by Boston Scientific, May 2017, $435M
------------------
If you believe any of this information is incorrect, please
let us know
.